Fertility preservation in female cancer sufferers: (only) a moral obligation?

References

• Muñoz M, Santaballa A, Seguí MA, et al. SEOM clinical guideline of fertility preservation and reproduction in cancer patients (2016). Clin Transl Oncol. 2016;18(12):1229–1236.
   PubMed Web of Science ®Google Scholar
• Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3–13.
   PubMedGoogle Scholar
• Kim SS, Donnez J, Barri P, ISFP Practice Committee, et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012;29(6):465–468.
   PubMed Web of Science ®Google Scholar
• Zoloth L, Henning AA. Bioethics and oncofertility: arguments and insights from religious traditions. Cancer Treat Res. 2010;156:261–278.
   PubMedGoogle Scholar
• Walsh SK, Ginsburg ES, Lehmann LS, et al. Oncofertility: fertile ground for conflict between patient autonomy and medical values. Oncologist. 2017;22(7):860–863.
   PubMed Web of Science ®Google Scholar
• Hanselin MR, Roybal DL, Leininger TB. Ethics and oncofertility: a call for religious sensitivity. J Oncol Pract. 2017;13(7):e582–e589.
   PubMed Web of Science ®Google Scholar
• Jones ASK, Shikanov A. Ovarian tissue cryopreservation and novel bioengineering approaches for fertility preservation. Curr Breast Cancer Rep. 2020;12(4):351–360.
   PubMed Web of Science ®Google Scholar
• Cho E, Kim YY, Noh K, et al. A new possibility in fertility preservation: the artificial ovary. J Tissue Eng Regen Med. 2019;13(8):1294–1315.
   PubMed Web of Science ®Google Scholar
• Zaami S, Marinelli E, di Luca NM, et al. Ethical and medico-legal remarks on uterus transplantation: may it solve uterine factor infertility? Eur Rev Med Pharmacol Sci. 2017;21(22):5290–5296.
   PubMed Web of Science ®Google Scholar
• Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility. Am Fam Physician. 2015;91(5):308–314.
   PubMed Web of Science ®Google Scholar
• Zaami S, Montanari Vergallo G, Napoletano S, et al. The issue of delivery room infections in the italian law. A brief comparative study with english and french jurisprudence. J Matern Fetal Neonatal Med. 2018;31(2):223–227.
   PubMed Web of Science ®Google Scholar
• Capozzi VA, Rosati A, Rumolo V, et al. Novelties of ultrasound imaging for endometrial cancer preoperative workup. Minerva Med. 2021;112(1):3–11.
   PubMed Web of Science ®Google Scholar
• Gullo G, Etrusco A, Cucinella G, et al. Fertility-Sparing approach in women affected by stage I and Low-Grade endometrial carcinoma: an updated overview. IJMS. 2021;22(21):11825.
   Google Scholar
• Ayensu-Coker L, Essig E, Breech LL, et al. Ethical quandaries in gamete-embryo cryopreservation related to oncofertility. J Law Med Ethics. 2013;41(3):711–719.
   PubMed Web of Science ®Google Scholar
• Cavaliere AF, Perelli F, Zaami S, et al. Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification. IJMS. 2021;22(22):12248.
   Google Scholar
• Anazodo A, Laws P, Logan S, et al. How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models of care. Hum Reprod Update. 2019;25(2):159–179.
   PubMed Web of Science ®Google Scholar
• Arecco L, Perachino M, Damassi A, et al. Burning questions in the oncofertility counseling of young breast cancer patients. Breast Cancer (Auckl)). 2020;14:1178223420954179.
   Web of Science ®Google Scholar
• Jungheim ES, Carson KR, Brown D. Counseling and consenting women with cancer on their oncofertility options: a clinical perspective. Cancer Treat Res. 2010;156:403–412.
   PubMedGoogle Scholar
• Zaami S, Montanari Vergallo G, Moscatelli M, et al. Oncofertility: the importance of counseling for fertility preservation in cancer patients. Eur Rev Med Pharmacol Sci. 2021;25(22):6874–6880.
   PubMed Web of Science ®Google Scholar
• Deshpande NA, Braun IM, Meyer FL. Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review. Cancer. 2015;121(22):3938–3947.
   PubMed Web of Science ®Google Scholar
• Logan S, Anazodo A. The psychological importance of fertility preservation counseling and support for cancer patients. Acta Obstet Gynecol Scand. 2019;98(5):583–597.
   PubMed Web of Science ®Google Scholar
• Speller B, Sissons A, Daly C, et al. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. BMC Health Serv Res. 2019;19(1):101.
   PubMedGoogle Scholar
• Ruddy KJ, Gelber SI, Tamimi RM, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. JCO. 2014;32(11):1151–1156.
   PubMed Web of Science ®Google Scholar
• Lawson AK, Klock SC, Pavone ME, et al. Prospective study of depression and anxiety in female fertility preservation and infertility patients. Fertil Steril. 2014;102(5):1377–1384.
   PubMed Web of Science ®Google Scholar
• Gonçalves V. Decisional regret in female oncofertility decision Making-An integrative narrative review. Cancers (Basel). 2021;13(19):4735.
   PubMed Web of Science ®Google Scholar
• Gullo G, Cucinella G, Perino A, et al. The gender gap in the Diagnostic-Therapeutic journey of the infertile couple. IJERPH. 2021;18(12):6184.
   Google Scholar
• Ethics committee of american society for reproductive medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100:1224–1231.
   PubMed Web of Science ®Google Scholar
• Loren AW, Mangu PB, Beck LN, American Society of Clinical Oncology, et al. Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–2510.
   PubMed Web of Science ®Google Scholar
• Lawson AK, Klock SC, Pavone ME, et al. Psychological counseling of female fertility preservation patients. J Psychosoc Oncol. 2015;33(4):333–353.
   PubMed Web of Science ®Google Scholar
• AYA cancer fertility preservation guidance working group. Fertility preservation for AYAs diagnosed with cancer: Guidance for health professionals. Sydney: Clinical Oncology Society of Australia. 2021. Available from: https://wiki.cancer.org.au/australia/COSA:AYA_cancer_fertility_preservation
   Google Scholar
• Fertility problems: assessment and treatment (Clinical Guidelines 156). National Institute for health and care excellence: NICE. 2013. Available from: https://www.nice.org.uk/guidance/cg156
   Google Scholar
• Klipstein S. AAP updates guidance for fertility preservation in patients with cancer. 2020. Available from: https://www.aappublications.org/news/2020/02/18/fertility021820
   Google Scholar
• La Rosa VL, Garzon S, Gullo G, et al. Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach. Ecancermedicalscience. 2020;14:1035.
   PubMed Web of Science ®Google Scholar
• Jones G, Hughes J, Mahmoodi N, et al. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23(4):433–457.
   PubMed Web of Science ®Google Scholar
• Bastings L, Baysal Ö, Beerendonk CC, et al. Deciding about fertility preservation after specialist counselling. Hum Reprod. 2014;29(8):1721–1729.
   PubMed Web of Science ®Google Scholar
• La Rosa VL, Valenti G, Sapia F, et al. Psychological impact of gynecological diseases: the importance of a multidisciplinary approach. It J Gynaecol Obstet. 2018;30:2.
   Google Scholar
• Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001.
   PubMed Web of Science ®Google Scholar
• Martinez F, International Society for Fertility Preservation–ESHRE–ASRM Expert Working Group. Update on fertility preservation from the barcelona international society for fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017;108(3):407–415.e11.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Amant F, Braat D, ESHRE Guideline Group on Female Fertility Preservation, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
   PubMedGoogle Scholar
• Cohn F. Oncofertility and informed consent: addressing beliefs, values, and future decision making. Cancer Treat Res. 2010;156:249–258.
   PubMedGoogle Scholar
• Italian Committee for Bioethics. Informazione e Consenso all’Atto Medico. 1992. Available from: http://www.dentistimadonnabianca.it/documents/03bis.InformazioneConsenso.CNB1992.pdf
   Google Scholar
• Temmerman M, Khosla R, Say L. Sexual and reproductive health and rights: a global development, health, and human rights priority. Lancet. 2014;384(9941):e30–e31.
   PubMed Web of Science ®Google Scholar
• International Covenant on Economic, Social and Cultural Rights. Adopted and opened for signature, ratification and accession by General Assembly resolution 2200A (XXI) of 16 December 1966, entry into force 3 January 1976, in accordance with article 27. 2021. Available from: https://www.ohchr.org/Documents/ProfessionalInterest/cescr.pdf
   Google Scholar
• United Nations Population Fund. Reproductive rights are human rights. A handbook for national human rights institutions. United Nations. 2014. Available from: https://www.ohchr.org/Documents/Publications/NHRIHandbook.pdf
   Google Scholar
• Larcher V. The ethical obligation to preserve fertility in the face of all therapies that might adversely affect it. Arch Dis Child. 2012;97(9):767–768.
   PubMed Web of Science ®Google Scholar
• Flores FJR, Velasco JAG, et al. GnRH antagonist protocols. In: Allahbadia GN, Ata B, Lindheim SR, editors. Textbook of assisted reproduction. Singapore: Springer Singapore; 2020. p. 89–95.
   Google Scholar
• Prapas Y, Ravanos K, Petousis S, et al. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial. J Assist Reprod Genet. 2017;34(11):1537–1545.
   PubMed Web of Science ®Google Scholar
• Bosch E, Broer S, Griesinger G, Ovarian Stimulation TEGGO, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(4):hoaa067..
   PubMedGoogle Scholar
• Marklund A, Eloranta S, Wikander I, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide swedish multicenter study. Hum Reprod. 2020;35:929–938.
   PubMed Web of Science ®Google Scholar
• Vaiarelli A, Cimadomo D, Conforti A, et al. Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the bologna criteria: a case series. Fertil Steril. 2020;113(1):121–130.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Wallberg KA, Waterstone M, Anastácio A. Ice age: cryopreservation in assisted reproduction - An update. Reprod Biol. 2019;19(2):119–126.
   PubMed Web of Science ®Google Scholar
• Cobo A, García-Velasco J, Domingo J, et al. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33(12):2222–2231.
   PubMed Web of Science ®Google Scholar
• Zaami S, Busardò FP. Elective egg freezing: can you really turn back the clock? Eur Rev Med Pharmacol Sci. 2015;19:3537–3538.
   PubMed Web of Science ®Google Scholar
• Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the danish cohort. J Assist Reprod Genet. 2018;35(4):561–570.
   PubMed Web of Science ®Google Scholar
• Diaz-Garcia C, Domingo J, Garcia-Velasco JA, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109(3):478–485.e2.
   PubMed Web of Science ®Google Scholar
• Poirot C, Fortin A, Lacorte JM, for the CAROLéLISA Cooperative Group, et al. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation. Hum Reprod. 2019;34(6):1083–1094.
   PubMed Web of Science ®Google Scholar
• Pegg DE. Principles of cryopreservation. Methods Mol Biol. 2007;368:39–57.
   PubMedGoogle Scholar
• Hunt CJ. Cryopreservation: vitrification and controlled rate cooling. Methods Mol Biol. 2017;1590:41–77.
   PubMedGoogle Scholar
• Amorim CA, Curaba M, Van Langendonckt A, et al. Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod Biomed Online. 2011;23(2):160–186.
   PubMed Web of Science ®Google Scholar
• Papatheodorou A, Vanderzwalmen P, Panagiotidis Y, et al. How does closed system vitrification of human oocytes affect the clinical outcome? A prospective, observational, cohort, noninferiority trial in an oocyte donation program. Fertil Steril. 2016;106(6):1348–1355.
   PubMed Web of Science ®Google Scholar
• Rivas Leonel EC, Lucci CM, Amorim CA. Cryopreservation of human ovarian tissue: a review. Transfus Med Hemother. 2019;46(3):173–181.
   PubMed Web of Science ®Google Scholar
• Kometas M, Christman GM, Kramer J, et al. Methods of ovarian tissue cryopreservation: is vitrification superior to slow freezing?-ovarian tissue freezing methods. Reprod Sci. 2021;28(12):3291–3302.
   PubMed Web of Science ®Google Scholar
• Shi Q, Xie Y, Wang Y, et al. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and Meta-anlaysis. Sci Rep. 2017;7(1):8538.
   PubMedGoogle Scholar
• Dalman A, Deheshkar Gooneh Farahani NS, Totonchi M, et al. Slow freezing versus vitrification technique for human ovarian tissue cryopreservation: an evaluation of histological changes, WNT signaling pathway and apoptotic genes expression. Cryobiology. 2017;79:29–36.
   PubMed Web of Science ®Google Scholar
• Gullo G, Petousis S, Papatheodorou A, et al. Closed vs. Open oocyte vitrification methods are equally effective for blastocyst embryo transfers: prospective study from a sibling oocyte donation program. Gynecol Obstet Invest. 2020;85(2):206–212.
   PubMed Web of Science ®Google Scholar
• Koch J, Ledger W. Ovarian stimulation protocols for onco-fertility patients. J Assist Reprod Genet. 2013;30(2):203–206.
   PubMed Web of Science ®Google Scholar
• Youssef MA, Van der Veen F, Hg A-I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014;10:CD008046.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1.
   PubMed Web of Science ®Google Scholar
• Campo-Engelstein L. For the sake of consistency and fairness: why insurance companies should cover fertility preservation treatment for iatrogenic infertility. Cancer Treat Res. 2010;156:381–388.
   PubMedGoogle Scholar
• Kawwass JF, Penzias AS, Adashi EY. Fertility-a human right worthy of mandated insurance coverage: the evolution, limitations, and future of access to care. Fertil Steril. 2021;115(1):29–42.
   PubMed Web of Science ®Google Scholar